Valeant's story: a cautionary tale

Mar 21, 2016
The company's CEO stepped down on Monday
Howard Schiller, then interim CEO of Valeant Pharmaceuticals International, Inc., listens during a hearing of the House Oversight and Government Reform Committee on Capitol Hill February 4, 2016 in Washington, DC. 
BRENDAN SMIALOWSKI/AFP/Getty Images

Bad packaging means $3b in drugs will be wasted this year

Mar 1, 2016
A new report suggests drug makers are profiting from the waste.
A new report suggests drug makers are profiting from the waste.
Peter Macdiarmid/Getty Images

How CVS reined in drug prices

by
Feb 23, 2016
Its Caremark unit covers some 25 million U.S. customers
Spencer Platt/Getty Images

A push for more transparency in drug research costs

Feb 16, 2016
The industry worries it's a step toward price controls.
Drug companies are not only in the spotlight for price setting, but now they may be required to be transparent about R&D spending. 
Kiran Foster/Flickr

How more generics could relieve sky-high drug prices

Feb 4, 2016
More generics are needed to create competition — but can the FDA approve them fast enough?
With high drug prices, more generics are needed to create competition, but can the FDA is having a hard time keeping up.
NVinacco/Flickr

Survey shows drug price hikes widespread in industry

Feb 4, 2016
It's not just a few bad players, as Congressional hearing puts drug costs in focus.
PHILIPPE HUGUEN/AFP/Getty Images

Congress turns its attention to high drug prices

Jan 21, 2016
This may actually lower drug costs.

For public good, not for profit.

Support fact-based, independent journalism with a gift to Marketplace today.

Congress aims to give some drugmakers a break

Oct 2, 2015
The push comes even as lawmakers discuss ways to rein in drug prices.